Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Teresa Delgado-Goni

Career Development Fellow

I am interested in imaging as a valuable tool for the diagnosis, new potential target identification and response to treatment detection in pathologies where a non-invasive approach is essential, as in the case of brain diseases. My previous research was focused on characterizing the metabolic response/resistance of preclinical brain tumours (and other types of cancer) to chemotherapeutic agents and targeted therapies using diverse imaging techniques (DCE-MRI, DWI, MRS, MRSI).

Nowadays, Parkinson’s disease is the second most common neurodegenerative disorder worldwide and a biomarker-based multimodal imaging approach could be very valuable for early diagnosis and drug target identification and validation. My aim now is to apply my imaging skills to the development of MRI and molecular imaging protocols (mainly based on [18F]-fluorodopa (FDOPA) uptake, imaged using positron emission tomography (PET)) to study the progressive neurodegenerative phenotype in previously established BAC-LRKK2 transgenic models that mimic the human disease, and compare these findings with clinical data.